These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24961874)

  • 1. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
    Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
    Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
    Sabki A; Khelifi L; Kameli A; Baali S
    Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
    Hess AP; Schanz A; Baston-Buest DM; Hirchenhain J; Stoff-Khalili MA; Bielfeld P; Kruessel JS
    J Reprod Immunol; 2009 Jan; 79(2):129-36. PubMed ID: 18996601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
    Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA
    J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1.
    Grabowska K; Puszko AK; Lipiński PFJ; Laskowska AK; Wileńska B; Witkowska E; Misicka A
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2843-2846. PubMed ID: 27142754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
    Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY
    Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
    Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y
    Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
    Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
    FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.
    Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A
    Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches.
    Mac Gabhann F; Popel AS
    PLoS Comput Biol; 2006 Dec; 2(12):e180. PubMed ID: 17196035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
    Liu W; Parikh AA; Stoeltzing O; Fan F; McCarty MF; Wey J; Hicklin DJ; Ellis LM
    Cytokine; 2005 Dec; 32(5):206-12. PubMed ID: 16289960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor.
    Liu WQ; Megale V; Borriello L; Leforban B; Montès M; Goldwaser E; Gresh N; Piquemal JP; Hadj-Slimane R; Hermine O; Garbay C; Raynaud F; Lepelletier Y; Demange L
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4254-9. PubMed ID: 25091928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.
    Grabowska K; Puszko AK; Lipiński PF; Laskowska AK; Wileńska B; Witkowska E; Perret GY; Misicka A
    Bioorg Med Chem; 2017 Jan; 25(2):597-602. PubMed ID: 27889287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
    Teran M; Nugent MA
    J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
    Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
    FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A
    Puszko AK; Sosnowski P; Pułka-Ziach K; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2493-2497. PubMed ID: 31326342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
    Bernatchez PN; Rollin S; Soker S; Sirois MG
    J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.
    Parker MW; Xu P; Guo HF; Vander Kooi CW
    PLoS One; 2012; 7(11):e49177. PubMed ID: 23145112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.